Brief: Prostatype Genomics Resolves On Directed Issue
06/08/2026 07:44
BRIEF-Prostatype Genomics Resolves On Directed Issue Aug 6 (Reuters) - Prostatype Genomics AB PROGEN.ST:
SAID ON WEDNESDAY BOARD RESOLVED TO CARRY OUT DIRECTED ISSUE OF UNITS
TO CARRY OUT DIRECTED ISSUE OF 3,423,452 UNITS
SUBSCRIPTION PRICE IS SEK 0.80 PER UNIT, CORRESPONDING TO SEK 0.10 PER SHARE
PURPOSE OF ISSUE, REASON FOR DEVIATING FROM SHAREHOLDERS' PREFERENTIAL RIGHTS, IS TO FULFIL CO'S OBLIGATIONS TOWARDS VATOR SECURITIES
Source text for Workspace: nMFN7qW4cX
Further company coverage: PROGEN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Prostatype Genomics AB
See all newsBrief: Prostatype Genomics Cannot Specify Timing For Final Medicare Decision
Brief: Prostatype Genomics Enters SEK 6.0 Mln Agreement With Vator Securities For To6
Brief: Prostatype Genomics AB H1 2026 Net Sales SEK 457,000
Brief: Prostatype Genomics Resolves On Directed Issue
Brief: Prostatype Genomics To Receive About SEK 47.4 Mln From Rights Issue